Sunday, October 20, 2024 - 10:40 am - 11:15 am

KEYNOTE ADDRESS
How the principles behind clinical trials inform practice in IBD; Some observations from four decades of experience as a clinical investigator

Learning Objectives:  

• To identify principles of clinical trials that are translatable in clinical practice.

Dr. Brian G. Feagan MD, FRCPC

Professor of Medicine, Epidemiology and Biostatistics
Western University, London, Ontario

Dr Brian G. Feagan is Professor of Medicine, Epidemiology and Biostatistics, Division of General Internal Medicine at Western University (Formerly The University of Western Ontario), London, Ontario, Canada. He became the Director of Robarts Clinical Trials at the Robarts Research Institute in 1997 and in 2020, the Senior Scientific Director of Alimentiv Inc. (formerly Robarts Clinical Trials). He completed his medical degree at Western University. His postdoctoral training included a residency in internal medicine and a clinical fellowship in gastroenterology in the Department of Medicine at Western University, and postgraduate training in the Department of Epidemiology and Biostatistics at McMaster University, Hamilton, Ontario. 

Dr Feagan’s research efforts focus on the design and implementation of randomized controlled trials of therapy for IBD. He has authored more than 500 articles and book chapters and has given over 1000 invited presentations at local, national, and international scientific meetings. He has also been the principal investigator on numerous large-scale randomized clinical trials.

A Fellow of the Royal College of Physicians and Surgeons of Canada, Dr Feagan holds membership in the Canadian and American Association of Gastroenterology, the American College of Gastroenterology, the College of Physicians and Surgeons of Ontario, Crohn’s and Colitis Canada (CCC), and the European Crohn’s and Colitis Organization (ECCO).